Vortagen

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Vortagen

What is Vortagen? Definition and Core Identity

Property Description
Active ingredient Diclofenac Sodium
Form Oral Solid Dosage (Capsule/Tablet)
Pharmacological class Nonsteroidal Anti-Inflammatory Drug (NSAID)
General purpose Pain, Inflammation, and Fever Reduction
Origin Synthetic (Phenylacetic acid derivative)

What Type of Medicine is Vortagen? (Definition and Classification)

Vortagen is a synthetic, prescription-only medicinal agent classified as a Nonsteroidal Anti-Inflammatory Drug (NSAID). Its core chemical component is Diclofenac, typically formulated as Diclofenac Sodium. This active substance is a phenylacetic acid derivative that functions as a potent Cyclooxygenase Inhibitor, blocking specific enzymes responsible for inflammatory responses. Diclofenac acts as an analgesic and anti-inflammatory agent, providing a dual action against pain and swelling. The compound is utilized for its effects across various inflammatory conditions.


Composition and Form: The Diclofenac Component

Vortagen is prepared as a single active ingredient product for oral administration, typically available as a tablet or specialized capsule. A unique characteristic of many formulations marketed under the Vortagen name is the use of an enteric coating. This structural feature protects the Diclofenac Sodium from stomach acid, ensuring the drug's release and primary absorption occur in the small intestine. This delayed-release design helps maintain the active ingredient's stability, providing relief for symptoms related to inflammatory conditions.


General Purpose and Core Benefit

The general purpose of Vortagen is to manage discomfort by providing simultaneous analgesic (pain-relieving) and anti-inflammatory activities. Its core benefit is the mitigation of physical symptoms like swelling, tenderness, and stiffness, such as the discomfort typically associated with joint pain. By inhibiting the synthesis of prostaglandins—chemical messengers that signal pain, inflammation, and fever—Vortagen provides systemic relief. This foundational action helps to lessen the severity of pain and accompanying physical symptoms, establishing its primary role in general symptom control and patient comfort.

Regulatory References

  1. (MedlinePlus, "Diclofenac")
  2. (NCBI, "Nonsteroidal Antiinflammatory Drugs")

What side effects are possible with Vortagen?

Vortagen: Possible Side Effects and Safety Information

Vortagen is an NSAID (nonsteroidal anti-inflammatory drug) that carries an increased risk of serious adverse reactions, which can occur at any time during treatment and may be fatal.

Serious and Clinically Significant Risks

Official regulatory information highlights a warning regarding two major categories of serious events:

  • Cardiovascular (CV) Thrombotic Events: Vortagen may increase the risk of serious CV events, including myocardial infarction (MI) and stroke. This risk may be increased with longer use and higher doses, and it is higher in patients with pre-existing heart disease or risk factors. Vortagen is generally contraindicated for peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery.
  • Gastrointestinal (GI) Adverse Events: Serious GI events, including inflammation, bleeding, ulceration, and perforation of the stomach or intestines, are documented risks. These events can occur without warning symptoms. Elderly patients and those with a prior history of peptic ulcer disease or GI bleeding are at greater risk.

Other Adverse Reactions and Safety Considerations

Adverse reactions commonly reported in patients treated with the drug include abdominal pain, constipation, diarrhea, dyspepsia, flatulence, edema, headache, and dizziness.

Less common but serious documented reactions involve the following:

  • Hypersensitivity and Skin: Severe allergic-type reactions, including anaphylaxis, and serious skin reactions such as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) have been reported.
  • Hepatic and Renal Effects: Elevated liver enzymes, liver failure, and severe renal issues, including kidney failure and fluid retention, are documented safety concerns. Close blood pressure monitoring is also required due to the risk of new or worsening hypertension.

Patients with known asthma, urticaria, or allergic reactions to aspirin or other NSAIDs are generally contraindicated from using Vortagen.

Overdose and Emergency Response

Overdose and When to Seek Help

This section describes the officially documented information regarding overdose of Vortagen (Diclofenac) as stated in government regulatory labeling.


Documented Overdose Manifestations

Overdose of Vortagen does not present a characteristic set of symptoms, but official labeling lists prominent effects involving the central nervous system and the gastrointestinal tract. Manifestations can range from nausea, vomiting (which may include blood), and epigastric pain to headache, dizziness, and drowsiness. In cases of severe intoxication, more serious signs such as seizures and coma are possible.

Severe outcomes that may occur include acute renal failure and major gastrointestinal bleeding (hemorrhage), particularly in the elderly population.


Required Emergency Actions

There is no specific antidote for a Vortagen overdose listed in official prescribing information. Management is supportive and symptomatic. Prompt medical intervention is vital for a better chance of recovery, and authorities require specific actions:

Required Action Description (Label-Based)
Immediate Medical Attention Seek immediate medical attention for all suspected overdoses. Contact emergency services or a Poison Control Center immediately.
Supportive Measures Treatment is symptomatic. Measures such as administering activated charcoal and potentially performing gastric lavage may be considered, especially if ingestion occurred recently.

Urgent medical help must be sought immediately for any suspected overdose situation.

Therapeutic Uses of Vortagen

What Vortagen Treats: Main Uses and Benefits

Vortagen is commonly used in situations involving certain distressing symptoms, applied across therapeutic domains where additional symptomatic support is needed. It is relevant for managing symptoms that interfere with daily comfort and may assist with easing the overall symptom load and helps maintain a sense of stability when symptoms are more noticeable. It is a relevant medication for addressing symptoms related to physical discomfort and conditions involving inflammatory or irritative processes.


Vortagen is generally considered relevant across conditions characterized by periods of heightened symptoms, including conditions involving episodic or fluctuating manifestations such as Osteoarthritis, Rheumatoid Arthritis, Ankylosing Spondylitis, primary dysmenorrhea (menstrual cramps), and migraine attacks. The medication may assist with easing symptom clusters that may become intense or disruptive, such as symptoms related to physical discomfort like joint pain, stiffness, swelling, and fever.

Applied across therapeutic domains where additional symptomatic support is needed for conditions marked by increased discomfort or tension.

Quick Fact: Relief for Inflammatory Discomfort

Primary Symptom Targeted Typical Use Scenario Patient Benefit
Pain and Swelling Post-traumatic injury or post-operative care Contributes to improved comfort during symptomatic phases.
Stiffness and Tenderness Chronic inflammatory joint diseases May assist with supporting functional stability and easing the overall symptom load.
Episodic Discomfort Acute pain flares or menstrual cycles Is relevant for providing supportive relief when symptoms interfere with routine activities.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Vortagen — Official Regulatory Information

This section outlines the eligibility criteria and formal restrictions for Vortagen use, strictly based on governmental regulatory documents.

Eligibility Scope Official Regulatory Statement
Populations Allowed Adult and pediatric patients 12 years and older who have a Grade 2 astrocytoma or oligodendroglioma tumor with a confirmed IDH1 or IDH2 mutation.
Populations Contraindicated The drug label does not list a specific formal contraindication; however, it includes strong warnings for certain conditions and populations.
Use Restricted/Avoided Avoid use in patients with advanced renal disease or severe heart failure unless the expected clinical benefits clearly outweigh the risks of worsening organ function.
Age-related Eligibility Eligible population starts at 12 years of age. Safety and efficacy have not been established in pediatric patients under 12 years.
Pregnancy Eligibility Status Prohibited/Avoided: The drug can cause fetal harm. Females of reproductive potential must use effective nonhormonal contraception during treatment and for a specified time after the last dose.
Lactation Eligibility Status Not Recommended: Patients are advised not to breastfeed during treatment and for a specified time after the last dose.

Eligibility Profile Summary

The regulatory eligibility profile for Vortagen is highly specific, requiring genetic confirmation of an IDH1 or IDH2 mutation in the tumor. While there is no absolute contraindication, strict limitations exist for patients with severe pre-existing conditions, particularly advanced renal disease and severe heart failure, where use is only permitted if the benefits are expected to outweigh the risks. Due to the potential for fetal harm and effects on breastfed infants, women who are pregnant, planning to be pregnant, or breastfeeding are explicitly advised to avoid use or employ nonhormonal contraception.

What should I know about interactions with other medicines?

The official regulatory profile for Vortagen details specific interactions involving pharmacokinetic and pharmacodynamic mechanisms that lead to restrictions on co-administration.

Contraindicated Combinations

The medicine is formally restricted for use in two specific scenarios. Vortagen is contraindicated for the treatment of peri-operative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery. It is also restricted in patients who have a history of allergic-type reactions, such as asthma or urticaria, following the use of Aspirin or other Nonsteroidal Anti-Inflammatory Drugs (NSAIDs).

Exposure Modification and Pharmacokinetics

Regulatory labeling documents that co-administration with Voriconazole causes a substantial increase in Vortagen’s plasma exposure ( C max and AUC), attributed to enzyme inhibition. Additionally, Vortagen use can increase the serum concentration of co-administered medicines, including Digoxin, Lithium, Methotrexate, and Cyclosporine, due to reduced clearance and elimination.

Pharmacodynamic and Risk Interactions

Interaction Type Interacting Medicines Official Outcome/Restriction
Additive Risk (Bleeding) Anticoagulants, SSRIs, SNRIs Increased risk of bleeding is officially stated.
Additive Risk (GI) Other Systemic NSAIDs, Salicylates Increased risk of serious gastrointestinal adverse events.
Antagonism/Renal Risk ACE Inhibitors, ARBs, Diuretics Diminished antihypertensive effect and risk of renal function deterioration.

Co-administration with ACE Inhibitors or ARBs carries a specific regulatory caution regarding the potential for deterioration of renal function, particularly in elderly or volume-depleted patients. Furthermore, the regulatory labeling notes that alcohol increases the risk for serious gastrointestinal bleeding, and administration with food may reduce the medicine's overall effectiveness in some formulations.

Mechanism of Action

How Vortagen Works

The mechanism of action for Vortagen (Diclofenac Sodium) is defined by its ability to interfere with a central inflammatory signaling cascade, resulting in the alteration in the intensity of specific physiological responses. The mechanism of action involves two principal mechanistic domains, which engage signaling pathways in both peripheral tissues and the central nervous system.


Enzyme Inhibition and Prostaglandin Synthesis

Vortagen acts as a non-selective, reversible inhibitor of the Cyclooxygenase (COX) enzymes, targeting both the COX-1 and COX-2 isoforms. By blocking the active site of these enzymes, the drug prevents the conversion of Arachidonic Acid into Prostaglandins—chemical messengers responsible for promoting nociceptor sensitization and initiating inflammatory tissue changes. This engagement modifies early molecular steps that define systemic physiological consequences.


Modulation of Nociceptive and Thermoregulatory Signaling

The altered concentration in Prostaglandin levels initiates a cascading physiological sequence. In peripheral tissues, this reduction contributes to the modulation of mediator activity by preventing the sensitization of local nociceptors and reducing local fluid extravasation. Centrally, the same enzymatic inhibition occurs in the hypothalamus, leading to the restoration of the body's thermoregulatory set-point, a mechanism that engages pathway modulation to re-establish internal equilibrium.

Dosage and Administration Information

How to Use Vortagen: Official Administration Guidelines

Vortagen (Diclofenac Sodium) is administered orally and its use is governed by the principle of utilizing the lowest effective dose for the shortest duration necessary.

The medication is available as Delayed-Release (enteric-coated) tablets (e.g., 25 mg, 50 mg, 75 mg) and Extended-Release tablets (typically 100 mg), based on standard therapeutic formulations.


Key Administration Instructions

Usage Domain Official Procedural Detail
Form Integrity Tablets and capsules must be swallowed whole. They must not be crushed, split, or chewed to preserve the modified-release design intended for intestinal absorption.
Timing Delayed-Release forms should be taken with liquid, preferably before meals.
Duration Usage should align with the required duration of treatment, adhering to the principle of using the minimum effective dose for the briefest period.

Standard Dosing Regimens

The total daily dosage is determined by the specific condition being managed and the formulation used, falling within established limits:

  • Delayed-Release: Daily dosages for chronic joint conditions generally range from 100 mg to 200 mg per day, administered in divided doses (two to four times daily).
  • Extended-Release: Typically administered as a single dose of 100 mg once daily.

No specific dose adjustment is typically specified for patients with mild to moderate renal dysfunction regarding the unchanged drug. These instructions establish the standardized approach to using the medicine.

Recent Clinical Evidence

Vortagen: Recent Clinical Evidence

Treatment Overview

The medication Vortagen is currently under investigation in studies focusing on outcomes related to pain management for individuals with knee osteoarthritis (OA) and low back pain. Research has investigated whether the drug's use is associated with changes in measures of pain and physical function in participants with knee OA.


Key Study Findings

Knee Osteoarthritis (OA)

Multiple clinical trials have evaluated the drug's role in the study of knee OA symptoms.

  • One study reported a statistically significant difference in the pain scores reported by participants receiving the treatment compared to a placebo group.
  • The reported findings related to pain were further explored within the context of symptom studies.
  • Another trial focused on whether the results associated with the drug were maintained over a six-month period.

Low Back Pain

Research has explored the drug's activity in relation to factors associated with chronic pain, specifically in individuals with low back pain.

  • The time course of the drug's activity and its association with changes in symptoms have been areas of investigation.
  • An analysis of a Phase 3 trial looked at changes in patient-reported disability scores.
  • Long-term data is being collected to evaluate results over an extended period.

Combination Therapy Research

Research has also examined Vortagen in combination with standard physical therapy.

  • This combination was studied to determine whether it is associated with changes in patient-reported quality of life measures.

Key Studies & References

  1. Diclofenac Action Pathway (Source for mechanistic details related to inflammatory pathways, used for contextual understanding in the low back pain section)
  2. A Real-World Evidence Study to Evaluate the Effects of Voltaren Use on Mobility and Quality of Life in Participants With Knee Osteoarthritis Pain (Source for combination therapy and QoL measurement in OA context)

Frequently Asked Questions (FAQ)

Common questions about Vortagen (FAQ)


Q: Is Vortagen used to treat high blood pressure?

Vortagen is officially described as a medicine for pain and inflammation, not for treating high blood pressure (hypertension). According to regulatory documents, the medication can potentially lead to new or worsening high blood pressure and may be restricted or contraindicated in patients with certain pre-existing heart conditions.


Q: How quickly should I expect to see an effect after starting Vortagen?

The time it takes to see an effect depends on the specific formulation you are using. Generally, formulations intended for acute symptoms, such as the immediate-release version, are described as having an expected quick onset of effect, typically used for the rapid management of acute symptoms.


Q: Do many people experience a metallic taste when taking Vortagen?

A metallic taste is not consistently documented as one of the most common or serious side effects in the official regulatory safety profiles for Vortagen.


Q: Is it true that Vortagen affects sleep patterns?

Official information indicates that sleepiness or drowsiness has been reported as an adverse reaction in studies of the active ingredient. If you experience changes in sleep patterns, official guidance recommends consultation with a healthcare professional.


Q: Can people with a history of kidney issues still use Vortagen?

The use of Vortagen is contraindicated or strongly restricted in patients with severe renal (kidney) impairment. For those with a general history of kidney issues, official guidance advises caution and close monitoring, and the decision to use the medicine in this circumstance requires careful consultation with a healthcare professional.


Q: Is Vortagen available as a generic medicine?

Yes, Vortagen contains the active ingredient Diclofenac Sodium or Potassium. This active component is widely available under many different generic names and brands that have been reviewed by regulatory bodies globally.


Q: Are there any specific foods to avoid while on Vortagen?

Official regulatory documents do not list specific foods that must be strictly avoided while taking Vortagen, apart from general administration guidance. However, official information notes that administration with food may reduce the medicine's overall effectiveness in certain formulations.


Q: Is Vortagen considered safe for long-term use?

Official regulatory advice strongly emphasizes utilizing the lowest effective dose for the shortest possible duration. Long-term use is associated with an increased risk of serious cardiovascular events, and continued use often necessitates periodic medical evaluation.


Q: What happens if a dose of Vortagen is missed?

Regulatory patient information advises that if you miss a scheduled dose, you should take it as soon as you remember. However, official patient information often describes a protocol to skip the missed dose and resume the normal schedule when it is almost time for the next dose.


Q: Can Vortagen be used by people over 65 years old?

The medicine can be used by people over 65, but official documents advise caution in this age group. Elderly patients are at a greater risk for serious side effects, and use in this population often involves closer monitoring due to increased risk.


Q: Are there any known interactions between Vortagen and herbal supplements?

Regulatory bodies generally advise that there is often not enough clear safety data to confirm that all herbal remedies, vitamins, and supplements are safe to use with Vortagen. The process of starting this medicine involves disclosing all supplements to the prescribing professional.


Q: What is the purpose of the different strengths (milligrams) of Vortagen?

Different strengths are manufactured to allow healthcare professionals to tailor a patient's treatment. The goal is always to prescribe the lowest effective dose necessary to achieve the recommended total daily dosage, which varies depending on the condition being treated and the formulation.


Q: Does Vortagen cause weight gain or weight loss?

While direct weight change is not a commonly listed side effect, Vortagen is associated with fluid retention and edema, which involves the accumulation of excess fluid. This fluid accumulation is a documented side effect.


Q: Can Vortagen be taken with common vitamins or minerals?

Official regulatory patient information advises patients to inform their healthcare team if they are taking any common vitamins or minerals. Informing the professional of all vitamins and minerals is part of the standard disclosure process for treatment.


Q: Is it okay to drive or operate machinery while taking Vortagen?

Official patient information often warns that Vortagen may cause certain side effects, such as dizziness or sleepiness. Official patient labeling includes warnings to avoid driving or operating machinery if these specific effects are experienced.


Q: Are there different brands of the medicine Vortagen?

Yes, because the active ingredient, Diclofenac, has been available for a long time, it is marketed under numerous different brand names and generic names across the world, which is acknowledged in regulatory safety communications.


Q: Does the time of day matter when taking Vortagen?

For the Delayed-Release tablets, official instructions recommend taking them with liquid, preferably before meals. For other formulations, the guidance is generally to take the medicine as instructed by your professional, prioritizing consistency in administration.


Q: Is Vortagen known to cause any changes in mood or behavior?

Although not common, documented adverse effects associated with the active ingredient include changes in mood, such as anxiety or depression, or general behavioral changes. Any change in mental state is a matter for consultation with a healthcare professional.


Q: What is the difference between the immediate-release and extended-release versions of Vortagen?

The difference relates to the speed at which the active ingredient is released into the body. Immediate- or Delayed-Release forms release the medication relatively quickly for rapid action, while the Extended-Release forms are specifically formulated to release the drug slowly over a longer period.


Q: How long does it usually take for the side effects of Vortagen to go away?

Most common side effects associated with Vortagen are expected to be mild and temporary. They generally resolve within a few days to weeks as the body adjusts to the medicine. If side effects persist or worsen, consultation with a healthcare provider is warranted.


Q: Can Vortagen be used if I am currently taking an antidepressant?

Warnings exist in official documents for combining Vortagen with certain types of antidepressants, specifically SSRIs and SNRIs, due to an increased risk of serious bleeding. Disclosing all current medications, including all classes of antidepressants, to the prescribing professional is a key requirement of the treatment process.


Q: Is Vortagen associated with any risk of serious eye problems?

While the oral form of the drug does not commonly list serious eye problems as a primary adverse reaction, the same active ingredient is used in eye drop formulations, which carry official warnings for rare but serious issues like corneal thinning or inflammation. Changes in vision are a matter for consultation with a healthcare professional.


Q: What is the typical duration of treatment with Vortagen?

Vortagen is intended for short-term treatment in acute conditions. For chronic management, regulatory bodies mandate that treatment duration should be the shortest necessary to achieve goals, often requiring periodic medical review if usage extends beyond several weeks.


Q: Is Vortagen a controlled substance?

No, the active ingredient in Vortagen, Diclofenac, is classified as a non-opioid, non-scheduled medication. It is not designated as a controlled substance by the U.S. Drug Enforcement Administration or most major international jurisdictions.


Q: Can people with heart disease use Vortagen?

Official regulatory documents explicitly contraindicate the use of Vortagen in patients with established cardiovascular disease, including ischaemic heart disease, peripheral arterial disease, and certain classifications of heart failure. The restrictions relate to the documented risk of serious cardiovascular events associated with the drug.


Q: Is Vortagen a blood thinner?

No, Vortagen is officially classified as a Nonsteroidal Anti-Inflammatory Drug (NSAID). However, because it carries an increased risk of bleeding when used with anticoagulants (blood thinners), official regulatory information advises specific precautions when these are used together.

How should Vortagen be stored and disposed of?

Storage Requirements

Official regulatory documents require that Vortagen (Diclofenac Sodium) be stored at controlled room temperature, specifically between 20 C and 25 C (68 F and 77 F). The medicine must be kept in its original container and the cap must be tightly closed to protect the product from moisture and excessive heat. Do not store the medicine in high-humidity areas, such as a bathroom.

Disposal Instructions

For proper disposal of unused or expired Vortagen, the regulatory preference is to use a drug take-back program at a local pharmacy or collection site. If a take-back program is unavailable, the drug should be mixed with an unappealing substance (like dirt or coffee grounds) and placed in a sealed bag before discarding in household trash. It is strictly prohibited to flush the medicine down the toilet. Ensure all personal information is removed from the label before disposal. The product must be kept out of the sight and reach of children.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Vortagen found in:

A-Z Index: